Sirona Dental Systems Earnings Call Nuggets: Omnicam vs. Bluecam Sales and Standalone Scanners

Sirona Dental Systems, Inc. (NASDAQ:SIRO) recently reported its first quarter earnings and discussed the following topics in its earnings conference call.

Omnicam vs. Bluecam Sales

Ross Taylor – CL King: Just maybe two or three quick questions. First, I wonder if you can give any color on what your mix of Omnicam versus Bluecam sales was in the quarter and whether you expect that might change much now that some of the capacity constraints seems to be have gone away?

Jost Fischer – Chairman and CEO: Good morning, Ross. This is Jost. Yes, we, of course, have a ramp-up in our Omnicam going on and therefore, the number of Omnicams were moving up throughout the quarter, but there was a very significant and solid demand for our other products in there, including the Bluecam.

Ross Taylor – CL King: Also, you mentioned that your new agreement with Patterson a few times. Can you give any color as to how that’s changing how you all are going to market and how it’s impacting or expanding demand? You did mention it a few times, and it sounds like it has been a nice benefit for you?

Jost Fischer – Chairman and CEO: Ross, we put all eggs in one basket in the U.S., expanded our agreement to include our entire product line, extended the exclusivity to 2017 and Patterson has committed to very challenging goals with us together and from that point, we now have the full attention of their sales force, and we are pretty well set up in this thing as you can see by 29% growth evidenced in this quarter.